PUBLIC COMPANY
save$VORVor Biopharma Inc.
$VOR23.07-2.18%Boston, MA, USupdated 6h ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Insider activity
source: SEC Form 4open-market buys + sells
- Apr 22, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$2.60M↗
- Apr 20, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$2.71M↗
- Apr 17, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$7.46M↗
- Apr 15, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$859K↗
- Apr 14, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$2.46M↗
- Apr 13, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$8.57M↗
- Apr 10, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$13K↗
- Apr 9, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$2.24M↗
- Apr 8, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$5.76M↗
- Apr 8, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$2.21M↗
- Apr 6, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$8.88M↗
- Apr 6, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$774K↗
- Apr 6, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$125K↗
- Apr 2, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$4.71M↗
- Apr 2, 26SELLRA CAPITAL MANAGEMENT, L.P.· −$29K↗
🐶 Hiring Signal
Where Vor Biopharma Inc. is staffing up — a leading indicator of pipeline and commercial priorities.
therapeutic areaImmunology & Inflammation 12CNS / Neuroscience 2
News
no news has mentioned this company yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that